Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePhase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors.AuthorsShimizu, Toshio; Nakajima, Takako Eguchi; Yamamoto, Noboru; Yonemori, Kan; Koyama, Takafumi; Kondo, Shunsuke; Sunakawa, Yu; Izawa, Naoki; Horie, Yoshiki; Xiang, Silong; Xu, Siying; Qin, Lan; Gong, John; Liu, DavidPublicationInvestigational New Drugs, 2022, Vol 40, Issue 5, p1021ISSN0167-6997Publication typeArticleDOI10.1007/s10637-022-01287-7